Anti-migraine treatments
US7314883B2 · kind B2 · utility
11Cited by
5References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2007 |
| Grant date | Jan 1, 2008 |
| Priority date | — |
| Expiry date | Jan 5, 2027 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2807
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating neurogenic vasodilation, neurogenic inflammaton, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors using pharmaceutical compositions comprising compounds of Formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.